to answer ur q from before, the notable 2 are IMU (11mil) and PYC which both have great preclin data and are tiny. IMU even has human data. ill froth a lil when we get the full data from that trial or better get when it goes into phase 1.
ps its great to see some proper discussion on this forum. not rubbish from fake posters or moookush and the constant ramblings of a poster clearly gone insane from the 5+yr wait
- Forums
- ASX - By Stock
- SPL
- Targeted DEP™ shows sustained superior performance in ovarian cancer model
Targeted DEP™ shows sustained superior performance in ovarian cancer model, page-79
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.6¢ |
Change
-0.002(2.04%) |
Mkt cap ! $40.06M |
Open | High | Low | Value | Volume |
9.6¢ | 9.6¢ | 9.6¢ | $279 | 2.903K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 19457 | 9.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.9¢ | 4558 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 19457 | 0.096 |
3 | 308325 | 0.095 |
4 | 360000 | 0.094 |
3 | 59659 | 0.093 |
2 | 134306 | 0.092 |
Price($) | Vol. | No. |
---|---|---|
0.099 | 4558 | 2 |
0.100 | 40048 | 3 |
0.105 | 209291 | 3 |
0.110 | 168286 | 9 |
0.115 | 103400 | 3 |
Last trade - 11.41am 08/10/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |